Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes

Kelei Dong(Shanghai Medical College of Fudan University), Meiling Wu(Shanghai Medical College of Fudan University), Xiaomin Liu(Shanghai Medical College of Fudan University), Yanjie Huang(Shanghai Medical College of Fudan University), Dongyang Zhang(Shanghai Medical College of Fudan University), Yiting Wang(Shanghai Medical College of Fudan University), Liang‐Jun Yan(University of North Texas), Dongyun Shi(Shanghai Medical College of Fudan University)
Free Radical Biology and Medicine
October 16, 2016
10.1016/j.freeradbiomed.2016.10.007
Cited by 53

Abstract

Related Papers

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
K. K. Srinivasan, Bhoomi Viswanad, Lydia Asrat et al.|Pharmacological Research|2005|1.9k
Islet   cell failure in type 2 diabetes
Marc Prentki|Journal of Clinical Investigation|2006|1.7k
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang, Gaochao Zhou, Li Cai|Cell Metabolism|2009|1k
A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
Michael Reed, Karl Meszaros, L. J. Entes et al.|Metabolism|2000|844
S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide
Takeshi Adachi, Robert M. Weisbrod, David R. Pimentel et al.|Nature Medicine|2004|648